Sinofn Health
Sinofn Health
Explore our highly requested ODM & OEM private label formulations engineered for target bio-availability and systemic performance.
Elevating cellular health, feed conversion ratios (FCR), and environmental sustainability through advanced molecular engineering.
The global animal husbandry and veterinary nutrition sectors are experiencing an unprecedented paradigm shift. Modern production systems no longer focus merely on gross protein intake; instead, they target the "Ideal Protein Concept." By matching dietary amino acid profiles precisely to the genetic potential of swine, poultry, aquaculture, and companion animals, producers can minimize metabolic stress and maximize yield.
Traditional raw feedstuffs (such as soybean meal and corn) often fall short of meeting the critical requirements for essential limiting amino acids—specifically L-Lysine, DL-Methionine, L-Threonine, and L-Tryptophan. Under traditional feeding paradigms, animal dietary crude protein levels were elevated to address these deficits. This approach resulted in severe biological efficiency losses, high nitrogen excretion, and increased production overhead.
Through SINOFN's specialized animal-grade amino acid solutions, livestock operations can safely reduce dietary crude protein by 2% to 4%. This mitigation lowers enteric ammonia emissions, supports intestinal mucosa integrity, and optimizes growth velocity.
In addition to free-form crystalline amino acids, the contemporary market demands specialized oligopeptides. Short-chain peptides, such as glutamine peptides and bioactive collagen peptides, bypass traditional amino acid transport systems (PAT1, etc.) inside the animal gut. They utilize the highly efficient PepT1 active transport pathway, which ensures rapid absorption even during enteric disease challenges.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the prestigious Chinese Academy of Sciences (CAS). Established in 2025, we operate from Shanghai as our central trading and logistics hub, ensuring seamless contract manufacturing services for premium, science-driven global partners.
Our founding DNA is rooted in solving complex metabolic issues. We apply the same rigorous scientific standards, clinical precision, and analytical parameters developed for human therapeutic nutrition directly to our advanced animal amino acid production and formulation capabilities.
Pioneering specialized diets for metabolic health, from human clinical nutrition to premium veterinary formulations.
Founder & Visionary Director
During her intensive clinical work, Mrs. Liu witnessed firsthand the lifelong struggles of PKU (Phenylketonuria) children, whose specialized low-protein diets were often financially out of reach for their families. Driven to bridge this critical therapeutic gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU medical foods.
Her dedication attracted strategic institutional investors and fueled transformative growth across multiple key domains:
Building exceptional product quality and molecular efficiency with an elite, multidisciplinary scientific board.
Medical Innovation Director
Ph.D. from Peking University Medical School. Over 15 years of dedicated specialization in complex metabolic disorder formulations, functional amino acid delivery, and cellular bio-compatibility.
R&D Lead Scientist
Associate Researcher & Postdoctoral Fellow, Chinese Academy of Sciences (CAS). Specialist in bio-active compound delivery systems, fermentation mechanics, and strain optimization.
Formulation & Engineering Director
Senior Scientist (Netherlands). Expert in European Union regulatory pathways, specialty dietary foods, and next-generation industrial-scale encapsulation technologies.
Through strategic collaboration with top academic institutions and internal team building, our scientific board continuously explores cutting-edge technology platforms. We are committed to providing premium clinical and industrial formulation services to our global corporate clients.
Uncompromising GMP compliance, automated processes, and strict quality control standards at our specialized manufacturing facility.
Over 10 dedicated advanced lines spanning softgels, gummies, powders, and tablets. Fully ISO 22000, HACCP, and FSSC 22000 certified with an annual capacity exceeding 500 million units.
Equipped with high-performance liquid chromatography (HPLC), GC-MS contaminant screening, heavy metal testing, and microbiological safety verification for every production batch.
Pilot-scale prototyping facilities for specialized micro-tablets, custom capsules, and nutrient liquids. Features comprehensive bioavailability and stability testing chambers.
Seamless material flow from raw material storage to synthesis, automated mixing, and final packaging. Supported by blockchain-enabled batch tracking and BRCGS-certified warehousing.
Why leading global enterprises choose SINOFN as their core ODM partner for animal-grade bioactive amino acids.
We benefit from direct access to China's leading upstream biochemical precursors and fermentation feedstocks, shielding our clients from global raw material price volatility.
Our engineering systems allow us to transition custom formulations from laboratory pilot validation to full commercial manufacturing runs within weeks, not months.
We assist our clients with complex regulatory documentation, including FDA dossiers, EU feed additive registrations, Halal verification, and customs clearance procedures.
Customizing formulation biochemistry to match the physiological profiles of target species.
Target: Weaned Piglets & Sows.
Optimized L-Tryptophan and L-Threonine ratios to improve gut health, minimize stress-induced diarrhea, and support lean tissue accretion.
Target: Broilers & Layers.
Highly bioavailable DL-Methionine and L-Lysine to accelerate feather development, improve carcass yield, and maintain consistent egg production.
Target: Shrimp & Carnivorous Fish.
Water-stable amino acid matrices and specialty peptide attractants that increase feed palatability, minimize leaching, and optimize survival rates.
Target: Premium Pet Food Brands.
Glutamine peptides and branched-chain amino acids (BCAAs) that support muscle synthesis, joint mobility, and healthy cognitive aging.
A transparent, verifiable look at our international safety certifications and technical patents.
Detailed, technical insights addressing common purchasing, production, and regulatory questions from our global partners.
Our corporate headquarters and primary manufacturing facilities are located in Tianjin and Shanghai, China. We operate a global logistics network, exporting custom animal amino acids, FSMP inputs, and functional health supplements to major agricultural and pet food markets across Europe, North America, Southeast Asia, and Latin America.
Yes. Our Tianjin R&D Center features dedicated pilot-scale prototyping machinery that mimics our commercial production lines. We support low-volume trial runs to test stability, taste profile (for pet foods), pellet integrity, and bio-availability before committing to full-scale commercial manufacturing.
We support brands of all sizes. For established enterprises, we provide large-scale, high-capacity contract manufacturing runs, competitive raw material contract pricing, and robust API/chemical verification. For growing startups, we offer tailored minimum order quantities (MOQs), comprehensive formulation services, and label regulatory reviews.
Every production run undergoes strict testing. Our testing center is equipped with high-resolution HPLC and GC-MS equipment. We verify that each batch meets regulatory safety parameters for lead, arsenic, mercury, residual solvents, mycotoxins, and common cross-contaminating allergens.
Our partnership with CAS grants us access to advanced bio-fermentation research, optimized microbial strains, and innovative encapsulation methodologies. This allows us to manufacture amino acid derivatives and peptide chains with high bio-availability and industrial stability.
Standard contract production runs typically require 4 to 6 weeks from initial formulation approval and raw material staging to packaging. Custom packaging or complex micro-encapsulation runs may extend this timeframe to 8 weeks. We provide clear, milestone-based tracking for every project.
Discover our highly bio-available protein supplements and specialized metabolic nutrition solutions.
